WINTHER: The WIN therapeutics clinical trial
13 Jul 2012
WINTHER: The WIN therapeutics clinical trial
Best treatment for chronic lymphocytic leukaemia with 17p deletion
Use of genetic variance to identify potential therapeutic targets
Application of next generation sequencing
Next generation sequencing and WIN therapeutics
Identifying targets with systems medicine
Shortening the timeline for clinical drug developments
Building international collaborations and the WINTHER trial
GFI is crucial for AML1-ETO induced acute myeloid leukemia
Signaling and targeting cellular pathways in leukaemia metabolism
Whole genome sequence analysis for acute lymphoblastic leukaemia
Next generation sequencing and the monoclonal structure of multiple myeloma